# Semaglutide Effects on Sleep Apnea in Patients With Type 2 Diabetes/Obesity and Comorbid Obstructive Sleep Apnea

> **NCT07281196** · — · COMPLETED · sponsor: **Shanghai Fengxian District Central Hospital** · enrollment: 15 (actual)

## Conditions studied

- Sleep Apnea Syndrome (OSAS)

## Interventions

- **DRUG:** Semaglutide Subcutaneous Injection

## Key facts

- **NCT ID:** NCT07281196
- **Lead sponsor:** Shanghai Fengxian District Central Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-01-31
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07281196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07281196, "Semaglutide Effects on Sleep Apnea in Patients With Type 2 Diabetes/Obesity and Comorbid Obstructive Sleep Apnea". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07281196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*